Armata Pharmaceuticals, Inc.
Recent Filings
All 1,000 filings →| Form | Description | Date |
|---|---|---|
| 10-K | 10-K | Mar 25, 2026 |
| 8-K | 8-K | Mar 25, 2026 |
| 8-K | FORM 8-K | Mar 19, 2026 |
| 4 | OWNERSHIP DOCUMENT | Mar 17, 2026 |
| 4 | OWNERSHIP DOCUMENT | Mar 17, 2026 |
| 4 | OWNERSHIP DOCUMENT | Mar 11, 2026 |
| 4 | OWNERSHIP DOCUMENT | Mar 11, 2026 |
| 4 | OWNERSHIP DOCUMENT | Mar 11, 2026 |
| 4 | OWNERSHIP DOCUMENT | Mar 11, 2026 |
| 4 | OWNERSHIP DOCUMENT | Mar 11, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Rychlik Richard | Corporate Controller and PFO | Award / Grant | 10,000 | 10,000 | Mar 14, 2024 |
| Birx Deborah | Chief Executive Officer | Award / Grant | 60,000 | 260,000 | Mar 14, 2024 |
| Birx Deborah | Chief Executive Officer | Award / Grant | 200,000 | 200,000 | Dec 21, 2023 |
| Innoviva, Inc. | — | Purchase | 5,385,208 @ $5.00 | 16,365,969 | Mar 31, 2022 |
| Innoviva Strategic Opportunities LLC | — | Purchase | 3,614,792 @ $5.00 | 10,980,761 | Feb 9, 2022 |
| Innoviva Strategic Opportunities LLC | — | Purchase | 1,212,122 @ $3.30 | 7,365,969 | Oct 29, 2021 |
| Innoviva, Inc. | — | Purchase | 4,285,935 @ $3.25 | 6,153,847 | Mar 17, 2021 |
| Innoviva Strategic Opportunities LLC | — | Purchase | 1,867,912 @ $3.25 | 1,867,912 | Jan 26, 2021 |
| Innoviva, Inc. | — | Purchase | 7,717,661 @ $2.87 | 8,710,800 | Mar 27, 2020 |
| GRINT PAUL C | Chief Executive Officer | Award / Grant | 599 @ $0.62 | 599 | Dec 8, 2017 |